IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Translational Neurodegeneration

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

10.88

h-Index

2022-2023

 54

Rank

2022-2023

 835

SJR

2022-2023

 2.571

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Translational Neurodegeneration
Abbreviation Transl. Neurodegener.
Publication Type Journal
Subject Area, Categories, Scope Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1)
h-index 54
Overall Rank/Ranking 835
SCImago Journal Rank (SJR) 2.571
Impact Score 10.88
Publisher BioMed Central Ltd.
Country United Kingdom
ISSN 20479158
Best Quartile Q1
Coverage History 2012-2022




About Translational Neurodegeneration


Translational Neurodegeneration is a journal covering the technologies/fields/categories related to Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1). It is published by BioMed Central Ltd.. The overall rank of Translational Neurodegeneration is 835. According to SCImago Journal Rank (SJR), this journal is ranked 2.571. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 54. The best quartile for this journal is Q1.

The ISSN of Translational Neurodegeneration journal is 20479158. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Translational Neurodegeneration is cited by a total of 1382 articles during the last 3 years (Preceding 2022).


Translational Neurodegeneration Impact IF 2022-2023


The Impact IF 2022 of Translational Neurodegeneration is 10.88, which is computed in 2023 as per its definition. Translational Neurodegeneration IF is increased by a factor of 1.9 and approximate percentage change is 21.16% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Translational Neurodegeneration Impact IF 2023 Prediction


Impact IF 2022 of Translational Neurodegeneration is 10.88. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Translational Neurodegeneration. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 10.88
2021 8.98
2020 7.90
2019 6.15
2018 5.86
2017 6.11
2016 4.67
2015 3.23
2014 4.16

Translational Neurodegeneration h-index


  Table Setting

Translational Neurodegeneration has an h-index of 54. It means 54 articles of this journal have more than 54 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Translational Neurodegeneration ISSN


The ISSN of Translational Neurodegeneration is 20479158. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Translational Neurodegeneration Rank and SCImago Journal Rank (SJR)


The overall rank of Translational Neurodegeneration is 835. According to SCImago Journal Rank (SJR), this journal is ranked 2.571. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Translational Neurodegeneration by Year


Year SJR
2023/2024 Coming Soon
2022 2.571
2021 1.849
2020 2.565
2019 1.812
2018 2.346
2017 1.901
2016 1.669
2015 1.461
2014 1.481

Ranking of Translational Neurodegeneration by Year


Year Ranking
2023/2024 Coming Soon
2022 835
2021 1426
2020 869
2019 1568
2018 1026
2017 1506
2016 1964
2015 2505
2014 2356

Translational Neurodegeneration Publisher


Table Setting

Translational Neurodegeneration is published by BioMed Central Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2012-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Translational Neurodegeneration is Transl. Neurodegener.. This abbreviation ('Transl. Neurodegener.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Translational Neurodegeneration


If your research field is/are related to Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Translational Neurodegeneration?

Translational Neurodegeneration latest impact IF is 10.88. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 10.88 (2022) and 3.23 (2015), respectively, in the last 9 years. Moreover, its average IS is 6.44 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Translational Neurodegeneration?

The Translational Neurodegeneration has an SJR (SCImago Journal Rank) of 2.571, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.571 in 2022 and the lowest being 1.461 in 2015. Furthermore, the average SJR of the Translational Neurodegeneration over the previous 9-year period stands at 6.44.


What's the latest h-index of the Translational Neurodegeneration?

The latest h-index of the Translational Neurodegeneration is 54.


Who's the publisher of the Translational Neurodegeneration?

The Translational Neurodegeneration is published by the BioMed Central Ltd., with its country of publication being the United Kingdom.


What's the current ranking of the Translational Neurodegeneration?

The Translational Neurodegeneration is currently ranked 835 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 835 in 2022 and its lowest position of 2505 in 2015.


What's the abbreviation or short name for the Translational Neurodegeneration?

The standard ISO4 abbreviation for the Translational Neurodegeneration is Transl. Neurodegener..


Is the "Translational Neurodegeneration" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Translational Neurodegeneration is classified as a journal that the BioMed Central Ltd. publishes.


What's the scope or major areas of the Translational Neurodegeneration?

The Translational Neurodegeneration encompasses the following areas:

  • Cellular and Molecular Neuroscience
  • Cognitive Neuroscience
  • Neurology (clinical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Translational Neurodegeneration?

The Translational Neurodegeneration is assigned the following International Standard Serial Numbers (ISSN): 20479158.


What's the best quartile of the Translational Neurodegeneration?

The best quartile for the Translational Neurodegeneration is Q1 (2022).


What's the coverage history of the Translational Neurodegeneration?

The Translational Neurodegeneration coverage history can be summarized as follows: 2012-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 10343 Vilnius Gediminas Technical University 45 2.81
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division conference and proceedings 17477 16 0.00
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
Clinical Medicine and Research journal 16602 Marshfield Clinic 60 1.06
Journal of Geriatric Physical Therapy journal 5578 Lippincott Williams and Wilkins Ltd. 43 1.80
Current Sociology journal 6591 SAGE Publications Ltd 76 2.29
Entrepreneurship Theory and Practice journal 338 Wiley-Blackwell 185 12.75
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
Discourse journal 6621 Routledge 59 2.11
Abacus journal 8398 Wiley-Blackwell Publishing Ltd 49 2.52

Check complete list




Year wise Impact Score (IS) of Translational Neurodegeneration

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 10.88
2021 8.98
2020 7.90
2019 6.15
2018 5.86
2017 6.11
2016 4.67
2015 3.23
2014 4.16



Top Journals/Conferences in Cellular and Molecular Neuroscience

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Molecular Psychiatry
Nature Publishing Group | United Kingdom

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neuroinflammation
BioMed Central Ltd. | United Kingdom

Acta neuropathologica communications
BioMed Central Ltd. | United Kingdom

GLIA
John Wiley & Sons Inc. | United States

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

Cell Death and Disease
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Cognitive Neuroscience

Trends in Cognitive Sciences
Elsevier Ltd. | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Alzheimer's Research and Therapy
BioMed Central Ltd. | United Kingdom

Neuroscience and Biobehavioral Reviews
Elsevier Ltd. | United Kingdom

NeuroImage
Academic Press Inc. | United States

Neural Networks
Elsevier Ltd. | United Kingdom

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Elsevier Inc. | United States

Developmental Science
Wiley-Blackwell Publishing Ltd | United Kingdom

Open Mind
MIT Press Journals | United States

Current Opinion in Behavioral Sciences
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

See All